株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のアレルギー診断・治療市場

Global Markets for Allergy Diagnostics and Treatments

発行 BCC Research 商品コード 324154
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.37円で換算しております。
Back to Top
世界のアレルギー診断・治療市場 Global Markets for Allergy Diagnostics and Treatments
出版日: 2017年06月15日 ページ情報: 英文 150 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界のアレルギー診断・治療市場は、2015年におよそ353億米ドルに達しました。市場は、2016年〜2021年のCAGR (複合年間成長率) で、5.9%の成長が予測されています。

当レポートでは、世界のアレルギー診断・治療市場について調査分析し、市場概要、市場動向、市場区分、アレルギー反応の種類、主要企業のプロファイルについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 アレルギーの概要

  • アレルギーの定義
  • アレルギーと喘息
  • アレルギーと気候変動
  • アレルギー反応の種類
  • 昆虫アレルギー
  • 皮膚アレルギー
  • 目のアレルギー
  • 薬物・生物剤に対するアレルギー
  • アレルギー検査メーカー
  • 免疫療法製品・メーカー
  • 抗アレルギー薬メーカー
  • 局所ステロイド治療
  • アナフィラキシー治療
  • アレルギー結膜炎治療
  • 一般的なアレルギー治療
  • アレルギー市場におけるM&A

第4章 世界のアレルギー診断市場

  • アレルギー診断製品市場の予測
  • 診断検査の種類
  • 地域別市場
  • 南北アメリカのアレルギー診断市場の予測
  • 南北アメリカのアレルギー診断市場:地域別
  • 欧州・中東・アフリカのアレルギー診断市場の予測
  • 欧州・中東・アフリカのアレルギー診断市場:地域別
  • アジアのアレルギー診断市場の予測
  • アジアのアレルギー診断市場:国別
  • アジア地域のアレルギー要因
  • アジアのアレルギー診断市場の予測

第5章 世界の免疫療法市場

  • SLIT (舌下免疫療法) 投与アプローチ
  • SLITによる免疫変化
  • 皮下免疫療法と舌下免疫療法の比較
  • 免疫療法製品
  • 免疫療法市場の参入企業
  • 地域別市場
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア

第6章 世界のアレルギー治療市場

  • 世界のアレルギー製品市場
  • アレルギー処方製品
  • アレルギーのジェネリック医薬品
  • 米国のジェネリック産業
  • OTCアレルギー製品
  • 抗アレルギー薬の種類
  • 抗ヒスタミン剤、抗ヒスタミン化合物
  • 交感神経様作用薬、鼻炎薬、併用
  • コルチコステロイドアレルギー製品
  • 肥満細胞安定剤
  • ロイコトリエン受容体
  • アナフィラキシー治療
  • アレルギー治療の地域別市場
  • アレルギー反応
  • 米国のアレルギー人口
  • アレルギー率:地域別
  • 南北アメリカのアレルギー治療市場
  • 欧州のアレルギー
  • アジアのアレルギー治療

第7章 アレルギー検査・治療の発展、最近の特許

  • 診断検査における新規開発
  • 治療の進歩
  • 免疫療法
  • アレルギー治療
  • 皮膚免疫療法

第8章 企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHM026C

The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021.

Report Includes

  • An overview of the global markets for allergy diagnostics and treatments.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of CAGRs through 2021.
  • Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
  • Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
  • Profiles of major players in the allergy diagnostics and treatments industry.

Report Scope

This BCC Research report is designed to provide a comprehensive look at the global allergy diagnostic, immunotherapy, and treatment markets. The geographic areas covered by the report include the Americas region (i.e., Canada, U.S., Mexico, and Central and South America); the EMRA region (i.e., Europe, the Middle East, Russia, and Africa); and the Asian region (i.e., Japan, China, India, Australia, New Zealand, and other Asian Pacific countries).

The report provides a brief explanation of different allergic disorders with global incidence rates; discusses the different types of allergy diagnostic tests and their applicability in diagnosing various allergens; describes classes of allergy treatment products; and provides an overview of the growing immunotherapy market. The report organizes information from diverse sources into a cohesive unit that includes:

  • A section on diagnostic products such as skin prick and patch tests, provocation testing, and antibody allergen testing.
  • An overview section on allergies and five categories of prescription allergy products including antihistamines and combinations; sympathomimetics, decongestants and combinations; corticosteroids; mast cell stabilizers; and leukotriene receptors.
  • Specific chapters that focus on testing and treatment in three distinct geographical areas: Americas, EMRA and Asia.
  • A company profiles section that provides background information on companies active in the diagnostic and treatment arenas.

Analyst Credentials

Vijay Laxmi has more than 20 years of experience in the healthcare domain. In addition to producing business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies. Her market research studies include reports on:

  • Various medical device markets.
  • High-growth and niche markets in healthcare and life sciences.
  • Home healthcare market.
  • Medical tourism.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources.
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Allergy Types
  • Projected Global Market
    • Global Allergy Diagnostic Market
    • Global Immunotherapy Market
    • Global Allergy Medication Market
  • Regional Diagnostic, Immunotherapy and Treatment Market Leaders
    • Diagnostic Market
    • Immunotherapy Market
    • Treatment Market

Chapter 3: Overview of Allergies

  • Definition of Allergies
  • Allergies and Asthma
  • Allergies and Climate Change
  • Types of Allergic Reactions
    • Environmental Allergies
    • Food Allergies
    • Latex Allergies
  • Insect Allergies
    • Diagnosis and Treatment
  • Skin Allergies
    • Atopic Eczema
    • Urticaria
    • Angioedema
  • Eye Allergies
    • Allergic Conjunctivitis
  • Allergies to Drugs and Biological Agents
  • Allergy Testing Manufacturers
  • Immunotherapy Products and Manufacturers
  • Allergy Medication Manufacturers
  • Topical Steroid Treatments
  • Anaphylaxis Treatments
  • Allergic Conjunctivitis Treatments
  • Generic Allergy Treatments
  • Mergers and Acquisitions in the Allergy Market

Chapter 4: Global Allergy Diagnostics Market

  • Projected Market for Allergy Diagnostic Products
  • Types of Diagnostic Tests
    • Skin Testing
    • Provocation Testing
    • Blood Analysis
  • Regional Marketplaces
  • Projected Americas Market for Allergy Diagnostics
  • Americas Allergy Diagnostic Market by Region
    • U.S.
    • Canada
    • Central and South America
  • Projected EMRA Market for Allergy Diagnostics
  • EMRA Allergy Diagnostic Market by Region
    • Europe
    • Middle East
    • Africa
  • Projected EMRA Allergy Diagnostic Market
  • Projected Asian Market for Allergy Diagnostics
  • Asian Allergy Diagnostic Market by Country
  • Allergic Triggers in Asian Region
    • Japan
    • China
    • India
  • Projected Asian Allergy Diagnostic Market

Chapter 5: Global Immunotherapy Market

  • SLIT Administration Approach
  • Immunologic Changes Following SLIT
  • Comparison of Subcutaneous Immunotherapy and Sublingual Immunotherapy
  • Single Antigen Versus Multi-Antigen Therapy
  • Immunotherapy Products
  • Immunotherapy Market Participants
  • Regional Markets
  • Americas
    • U.S.
    • Brazil
  • EMRA
    • Western Europe
    • Middle East
  • Asia
    • Japan
    • China

Chapter 6: Global Allergy Treatment Market

  • Global Market for Allergy Products
  • Prescription Allergy Products
  • Generic Allergy Products.
    • Market Drivers
  • Generic Industry in the U.S.
  • OTC Allergy Products
  • Types of Allergy Medications
  • Antihistamines and Antihistamine Combinations
    • Benefits/Disadvantages
    • Antihistamine Products
    • Market Size for Antihistamines and Antihistamine Combinations
  • Sympathomimetics, Decongestants and Combinations
    • Overview.
    • Benefits/Disadvantages
    • Sympathomimetics, Decongestants and Combinations Market Size
  • Corticosteroid Allergy Products
    • Overview.
    • Benefits/Disadvantages
    • Corticosteroid Market Size
  • Mast Cell Stabilizers
    • Overview.
  • Leukotriene Receptors
  • Anaphylaxis Treatment
  • Regional Markets for Allergy Treatments
    • Treatment Costs
  • Allergic Reactions
  • Allergy Population in the U.S.
    • Regional Variations
    • Sensitization by Gender
    • Sensitization by Age
  • Allergy Rates by Region.
  • Americas Allergy Treatment Market
    • Americas Allergy Treatment Products by Region/Country
    • South and Central American Treatment Market
  • Allergies in Europe
    • Projected EMRA Market for Prescription, Generic and OTC Allergy Products
    • Allergy Treatment in Russia
  • Allergy Treatment in Asia
    • Japan
    • China
    • India
    • Australia/New Zealand

Chapter 7: Developments in Allergy Testing and Treatment, and Recent Patents

  • New Developments in Diagnostic Testing
    • Allergen Component-resolved Diagnostics
  • Advances in Treatments
    • Chinese Herbal Medicine
  • Immunotherapy
    • Anergis
    • B-cell Epitope-based Immunotherapy
    • Nasal Filters
  • Allergy Therapeutics
  • Epicutaneous Immunotherapy
    • Anti-interleukin-31 Receptor A Antibody for Atopic Dermatitis

Chapter 8: Company Profiles

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Table 1 Summary Table: Global Allergy Diagnostic and Treatment Markets, by Type, Through 2021 ($ Millions)
  • Table 2 Most Common Food Allergies in the U.S. and Europe
  • Table 3 Food Allergens (in Order of Decreasing Prevalence) in Various Countries
  • Table 4 Tests for Food Allergies
  • Table 5 Potential Triggers for Hives
  • Table 6 Allergy Testing Manufacturers by Company and Location
  • Table 7 Allergy Immunotherapy Manufacturers by Company and Type of Product
  • Table 8 Allergy Medication Manufacturers by Company, Product Name, Type, Formulation and Indication for Use of Product
  • Table 9 Topical Steroid Medication Manufacturers by Potency, Company, Product Name and Formulation
  • Table 10 Anaphylaxis Medication Manufacturers by Company, Product Name, Type, Formulation and Indication for Use of Product
  • Table 11 Allergic Conjunctivitis Medication Manufacturers by Company, Product Name Type and Formulation
  • Table 12 Generic Allergy Medication Manufacturers by Type, Product Name, Formulation and Indication
  • Table 13 Selected Mergers and Acquisitions Pertinent to the Allergy Diagnostic and Treatment Market, 2009-2017
  • Table 14 Global Market for Allergy Diagnostic Products by Type, Through 2021 ($ Millions)
  • Table 15 Global Appropriate Testing for Allergies, by Type of Allergy and Test
  • Table 16 Global Market for Allergy Diagnostic Products, by Region, Through 2021 ($ Millions)
  • Table 17 Americas Market for Allergy Diagnostic Products by Type of Test, Through 2021 ($ Millions)
  • Table 18 Americas Market for Allergy Diagnostic Products by Region/Country, Through 2021 ($ Millions)
  • Table 19 EMRA Market for Allergy Diagnostic Products, by Type of Test, Through 2021 ($ Millions)
  • Table 20 EMRA Market for Allergy Diagnostic Products by Region/Country, Through 2021 ($ Millions)
  • Table 21 Asian Market for Allergy Diagnostic Products, by Type of Test, Through 2021 ($ Millions)
  • Table 22 Comparative Population Prevalence of Diagnosed Nasal Allergies (%)
  • Table 23 Asian Market for Allergy Diagnostic Products, by Region/Country, Through 2021 ($ Millions)
  • Table 24 Global Market for Immunotherapy Allergy Products by Form of Administration, Through 2021 ($ Millions)
  • Table 25 Allergen Sublingual and Injectable Allergen Extract Immunotherapy Treatments, by Type
  • Table 26 Global Market for Immunotherapy Products, by Region, Through 2021 ($ Millions)
  • Table 27 Americas Market for Immunotherapy Products, by Region/Country, Through 2021 ($ Millions)
  • Table 28 EMRA Market for Immunotherapy Products, by Region/Country, Through 2021 ($ Millions)
  • Table 29 Asia Market for Immunotherapy Products, by Region/Country, Through 2021 ($ Millions)
  • Table 30 Global Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
  • Table 31 Global Market for Prescription Allergy Treatment Products, by Form of Administration, Through 2021 ($ Millions)
  • Table 32 Global Market for Generic Allergy Treatment Products, by Form of Administration, Through 2021 ($ Millions)
  • Table 33 Global Market for OTC Allergy Treatment Products, by Form of Administration, Through 2021 ($ Millions)
  • Table 34 Global Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
  • Table 35 Antihistamine and Antihistamine Combination Products, 2017
  • Table 36 Global Market for Antihistamine and Antihistamine Combinations, by Form of Administration, Through 2021 ($ Millions)
  • Table 37 Available Sympathomimetics, Decongestants and Combinations, by Name and Manufacturer, 2017
  • Table 38 Global Market for Sympathomimetics, Decongestants and Combinations by Form of Administration, Through 2021 ($ Millions)
  • Table 39 Corticosteroid Preparations, by Name and Manufacturer
  • Table 40 Global Market for Allergy Corticosteroids, by Form of Administration, Through 2021 ($ Millions)
  • Table 41 Global Market for Allergy Mast Cell Stabilizers, by Form of Administration, Through 2021 ($ Millions)
  • Table 42 Global Market for Leukotriene Receptor Treatment Products, Through 2021 ($ Millions)
  • Table 43 Global Market for Allergy Treatment Products, by Region, Through 2021 ($ Millions)
  • Table 44 Estimated Costs for Treating Allergies in the U.S., 2012 ($ Billions)
  • Table 45 Worst U.S. Cities for Fall Allergies, 2016
  • Table 46 Americas Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
  • Table 47 Americas Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
  • Table 48 Americas Market for Allergy Treatment Products, by Region/Country, Through 2021 ($ Millions)
  • Table 49 Features of Food Allergy in Latin America
  • Table 50 EMRA Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
  • Table 51 EMRA Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
  • Table 52 EMRA Market for Allergy Treatment Products, by Region/Country, Through 2021 ($ Millions)
  • Table 53 Asia Market for Allergy Treatment Products, by Type, Through 2021 ($ Millions)
  • Table 54 Medications for Allergy Treatment in India, by Name, Type and Condition, 2016
  • Table 55 Asian Market for Allergy Treatment Products, by Region/Country, Through 2021 ($ Millions)
  • Table 56 Alere's Product Portfolio
  • Table 57 Alere's Recent Developments, 2015-February 2017
  • Table 58 Allergan's Product Portfolio
  • Table 59 Allergan's Recent Developments, 2015-February 2017
  • Table 60 Alcon Laboratories' Product Portfolio
  • Table 61 ALK-Abelló's Product Portfolio
  • Table 62 ALK-Abelló's Recent Developments, 2015-February 2017
  • Table 63 Allergy Laboratories' Product Portfolio
  • Table 64 Allergopharma AG's Product Portfolio
  • Table 65 Amedra's Product Portfolio
  • Table 66 Amedra's Recent Developments, 2015-February 2017
  • Table 67 Ani Biotech Oy's Product Portfolio
  • Table 68 Aqua Pharmaceuticals' Product Portfolio
  • Table 69 Aqua Pharmaceuticals' Recent Development, 2015-February 2017
  • Table 70 Beckman Coulter's Product Portfolio
  • Table 71 Beckman Coulter's Recent Developments, 2015-February 2017
  • Table 72 Biomerica Inc.'s Product Portfolio
  • Table 73 Cortez Diagnostics' Product Portfolio
  • Table 74 Ferndale's Product Portfolio
  • Table 75 First Diagnostic's Product Portfolio
  • Table 76 Gladerma's Product Portfolio
  • Table 77 Gladerma's Recent Developments, 2015-February 2017
  • Table 78 GlaxoSmithKline's Product Portfolio
  • Table 79 GlaxoSmithKline's Recent Developments, 2015-February 2017
  • Table 80 Greer's Human Allergy Product Portfolio
  • Table 81 HAL Allergy Group's Product Portfolio
  • Table 82 HAL Allergy Group's Recent Developments, 2015-February 2017
  • Table 83 Hitachi Chemical Diagnostics' Product Portfolio
  • Table 84 Hitachi Chemical Diagnostics' Recent Developments, 2015-February 2017
  • Table 85 Hycor Biomedical's Product Portfolio
  • Table 86 Hycor Biomedical's Recent Developments, 2015-February 2017
  • Table 87 Johnson & Johnson's Product Portfolio
  • Table 88 Johnson & Johnson's Recent Development, 2015-February 2017
  • Table 89 Jubilant HollisterStier's Product Portfolio
  • Table 90 Kyowa Hakko Kirin's Product Portfolio
  • Table 91 Kyowa Hakko Kirin's Recent Development, 2015-February 2017
  • Table 92 LabCorp's Product Portfolio
  • Table 93 LabCorp's Recent Acquisitions, 2015-February 2017
  • Table 94 Lincoln Diagnostics' Product Portfolio
  • Table 95 Lupin's Product Portfolio
  • Table 96 Lupin's Recent Developments, 2015-February 2017
  • Table 97 Meda's Product Portfolio
  • Table 98 Meda's Recent Development, 2015-February 2017
  • Table 99 Merck's Product Portfolio
  • Table 100 Merck's Recent Developments, 2015-February 2017
  • Table 101 Mylan's Product Portfolio
  • Table 102 Mylan's Recent Developments, 2015-February 2017
  • Table 103 Pfizer's Product Portfolio
  • Table 104 Pfizer's Recent Developments, 2015-February 2017
  • Table 105 Pierre Fabre's Product Portfolio
  • Table 106 Pierre Fabre's Recent Developments, 2015-February 2017
  • Table 107 Quest Diagnostics' Product Portfolio
  • Table 108 Quest Diagnostics' Recent Developments, 2015-February 2017
  • Table 109 Ranbaxy Product Portfolio
  • Table 110 Roche's Product Portfolio
  • Table 111 Roche's Recent Developments, 2015-February 2017
  • Table 112 Sandoz's Product Portfolio
  • Table 113 Sandoz's Recent Developments, 2015-February 2017
  • Table 114 Sanofi's Product Portfolio
  • Table 115 Sanofi's Recent Developments, 2015-February 2017
  • Table 116 Siemens Healthcare's Product Portfolio
  • Table 117 Siemens Healthcare's Recent Developments, 2015-February 2017
  • Table 118 SmartPractice Denmark's Product Portfolio
  • Table 119 Terumo Medical's Products Portfolio
  • Table 120 Terumo Medical's Recent Developments, 2015-February 2017
  • Table 121 Thermo Fisher Diagnostics' Product Portfolio
  • Table 122 Thermo Fisher Diagnostics' Recent Developments, 2015-February 2017
  • Table 123 UCB's Product Portfolio
  • Table 124 UCB's Recent Development, 2015-February 2017161

List of Figures

  • Figure 1 Summary Figure: Global Allergy Diagnostic and Treatment Market, by Region, 2016 and 2021 (%)
  • Figure 2 Allergy Diagnostic Manufacturer Market by Country, 2014 (%)
  • Figure 3 Global Market for Allergy Diagnostic Testing Products by Type, 2016 and 2021 (%)
  • Figure 4 Global Market for Allergy Diagnostic Products, by Region, 2016 and 2021 (%)
  • Figure 5 Americas Market for Allergy Diagnostic Products by Type of Test, 2016 and 2021 (%)
  • Figure 6 Americas Market for Allergy Diagnostic Products by Region/Country, 2016 and 2021 (%)
  • Figure 7 EMRA Market for Allergy Diagnostic Products by Type of Test, 2016 and 2021 (%)
  • Figure 8 EMRA Market for Allergy Diagnostic Products by Region/Country, 2016 and 2021 (%)
  • Figure 9 Asian Market for Allergy Diagnostic Products by Type of Test, 2016 and 2021 (%)
  • Figure 10 Diagnosis for Allergic Rhinitis in China, 2011 (%)
  • Figure 11 Asian Market for Allergy Diagnostic Products, by Region/Country, 2016 and 2021 (%)
  • Figure 12 Global Market for Immunotherapy Allergy Products by Form of Administration, 2016 and 2021 (%)
  • Figure 13 Market Analysis for Immunotherapy Products by Participant, 2014 (%)
  • Figure 14 Global Market for Immunotherapy Products, by Region, 2016 and 2021 (%)
  • Figure 15 Americas Market for Immunotherapy Products, by Region/Country, 2016 and 2021 (%)
  • Figure 16 EMRA Market for Immunotherapy Products, by Region/Country, 2016 and 2021 (%)
  • Figure 17 Asia Market for Immunotherapy Products, by Region/Country, 2016 and 2021 (%)
  • Figure 18 Global Market for Allergy Treatment Products, by Type, 2016 and 2021 (%)
  • Figure 19 Global Market for Generic Allergy Treatment Products, by Form of Administration, 2016 and 2021 (%)
  • Figure 20 Global Market for OTC Allergy Treatment Products, by Form of Administration, 2016 and 2021 (%)
  • Figure 21 Global Market for Allergy Treatment Products, by Type, 2016 and 2021 (%)
  • Figure 22 Global Market for Antihistamine and Antihistamine Combinations, by Form of Administration, 2016 and 2021 (%)
  • Figure 23 Global Market for Allergy Treatment Products, by Region, 2016 and 2021 (%)
  • Figure 24 Allergy Demographics, by Type or Cause, 2012 (%)
  • Figure 25 Percentage of U.S. Population With and Without Allergies, 2016 and 2021 (%)
  • Figure 26 Regions/Countries Within the Americas With Highest Concentrations of Diagnosed Allergy Cases, 2013 (%)
  • Figure 27 Americas Market for Allergy Treatment Products, by Type, 2016 and 2021 (%)
  • Figure 28 EMRA Market for Allergy Treatment Products, by Type, 2016 and 2021 (%)
  • Figure 29 Asia Market for Allergy Treatment Products, by Region/Country, 2016 and 2021 (%)
Back to Top